RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation Application (MAA) for Talicia for treatment ...
Clinical Trials Arena on MSN1d
AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancerUS-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...
AbbVie (ABBV) announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE in women ...
Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival - - ...
--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, announced that its eConsent and eCOA solutions have been approved ... for Phase II and Phase III trials ...
If the test indicates that a woman has womb cancer, then the woman would need a biopsy to confirm or rule out the diagnosis. The test, by University College London (UCL) spinout company Sola ...
Women with signs of womb cancer can be offered a less invasive ... spinout company Sola Diagnostics, has been approved for use in the UK by the Medicines and Healthcare products Regulatory Agency ...
A less invasive test for detecting signs of womb cancer has been approved for use in the UK, offering women a simpler alternative to traditional diagnostic methods. The new health test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback